These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35577225)

  • 1. Recommendations of the Spanish Group on Crohn's Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients.
    Ferreiro-Iglesias R; Piqueras M; Ricart E; Sempere L; Roca M; Martín de Carpi J; Benítez O; Zabana Y; Mañosa M; Rodríguez-Moranta F; Barreiro-de Acosta M;
    Gastroenterol Hepatol; 2022 Dec; 45(10):805-818. PubMed ID: 35577225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease.
    Riestra S; Taxonera C; Zabana Y; Carpio D; Beltrán B; Mañosa M; Gutiérrez A; Barreiro-de Acosta M
    Gastroenterol Hepatol; 2021 Jan; 44(1):51-66. PubMed ID: 32828562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: implications on public health policies.
    García-Serrano C; Mirada G; Marsal JR; Ortega M; Sol J; Solano R; Artigues EM; Estany P
    BMC Public Health; 2020 May; 20(1):713. PubMed ID: 32429900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
    Gomollón F; Rubio S; Charro M; García-López S; Muñoz F; Gisbert JP; Domènech E;
    Gastroenterol Hepatol; 2015 Jan; 38(1):24-30. PubMed ID: 25454602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.
    Bermejo F; Aguas M; Chaparro M; Domènech E; Echarri A; García-Planella E; Guerra I; Gisbert JP; López-Sanromán A;
    Gastroenterol Hepatol; 2018 Mar; 41(3):205-221. PubMed ID: 29357999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.
    Marín AC; Gisbert JP; Chaparro M
    World J Gastroenterol; 2015 Oct; 21(40):11273-81. PubMed ID: 26527572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU.
    Yamamoto-Furusho JK; Andrade D; Barahona J; Bautista S; Bosques-Padilla F; de Paula J; Galiano MT; Iade B; Juliao-Baños F; Otoya G; Steinwurz F; Torres E; Veitia G; Barreiro-de Acosta M
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(1):89-102. PubMed ID: 34866040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinations in patients with inflammatory bowel disease.
    Macaluso FS; Liguori G; Galli M
    Dig Liver Dis; 2021 Dec; 53(12):1539-1545. PubMed ID: 34116972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.
    Barreiro-de Acosta M; Marín-Jiménez I; Panadero A; Guardiola J; Cañas M; Gobbo Montoya M; Modino Y; Alcaín G; Bosca-Watts MM; Calvet X; Casellas F; Chaparro M; Fernández Salazar L; Ferreiro-Iglesias R; Ginard D; Iborra M; Manceñido N; Mañosa M; Merino O; Rivero M; Roncero O; Sempere L; Vega P; Zabana Y; Mínguez M; Nos P; Gisbert JP
    Gastroenterol Hepatol; 2018 Feb; 41(2):118-127. PubMed ID: 29275001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
    Lamb CA; Kennedy NA; Raine T; Hendy PA; Smith PJ; Limdi JK; Hayee B; Lomer MCE; Parkes GC; Selinger C; Barrett KJ; Davies RJ; Bennett C; Gittens S; Dunlop MG; Faiz O; Fraser A; Garrick V; Johnston PD; Parkes M; Sanderson J; Terry H; ; Gaya DR; Iqbal TH; Taylor SA; Smith M; Brookes M; Hansen R; Hawthorne AB
    Gut; 2019 Dec; 68(Suppl 3):s1-s106. PubMed ID: 31562236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Grade Dysplasia in Inflammatory Bowel Disease: Indication for Colectomy.
    Olecki EJ; Perez Hoguin RA; King S; Razavi NC; Scow JS
    Dis Colon Rectum; 2023 Feb; 66(2):262-268. PubMed ID: 35714339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN.
    Martinelli M; Giugliano FP; Strisciuglio C; Urbonas V; Serban DE; Banaszkiewicz A; Assa A; Hojsak I; Lerchova T; Navas-López VM; Romano C; Sladek M; Veres G; Aloi M; Kucinskiene R; Miele E
    Inflamm Bowel Dis; 2020 Aug; 26(9):1407-1414. PubMed ID: 31689349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.
    Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania infection in patients with inflammatory bowel disease: Case series and literature review.
    Gimeno-Pitarch L; Almela P; Nos P
    Gastroenterol Hepatol; 2024 Jan; 47(1):82-92. PubMed ID: 37061089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis.
    Rodríguez-Moranta F; Argüelles-Arias F; Hinojosa Del Val J; Iborra Colomino M; Martín-Arranz MD; Menchén Viso L; Muñoz Núñez F; Ricart Gómez E; Sánchez-Hernández JG; Valdés-Delgado T; Guardiola Capón J; Barreiro-de Acosta M; Mañosa Ciria M; Zabana Abdo Y; Gutiérrez Casbas A
    Gastroenterol Hepatol; 2024 May; 47(5):522-552. PubMed ID: 38311005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of anti-TNF therapy (biologics) in the treatment of chronic inflammatory bowel disease in children].
    Kolacek S
    Acta Med Croatica; 2013 Apr; 67(2):89-92. PubMed ID: 24471292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.